|
Pronunciation |
|
(MA
fe
nide) |
|
|
U.S. Brand
Names |
|
Sulfamylon®
Topical |
|
|
Generic
Available |
|
No |
|
|
Synonyms |
|
Mafenide Acetate |
|
|
Pharmacological Index |
|
Antibiotic, Topical |
|
|
Use |
|
Adjunct in the treatment of second and third degree burns to prevent
septicemia caused by susceptible organisms such as Pseudomonas
aeruginosa; prevention of graft loss of meshed autografts on excised burn
wounds |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Contraindications |
|
Hypersensitivity to mafenide, sulfites, or any component |
|
|
Warnings/Precautions |
|
Use with caution in patients with renal impairment and in patients with
G-6-PD deficiency; prolonged use may result in
superinfection |
|
|
Adverse
Reactions |
|
>10%:
Central nervous system: Pain
Local: Burning sensation, excoriation
1% to 10%:
Cardiovascular: Facial edema
Dermatologic: Rash
Miscellaneous: Dyspnea
<1%: Erythema, hyperchloremia, metabolic acidosis, bone marrow
suppression, hemolytic anemia, bleeding, porphyria, hyperventilation, tachypnea,
hypersensitivity |
|
|
Drug
Interactions |
|
No data reported |
|
|
Stability |
|
Mafenide 5% topical solution preparation:
Dissolve the 50 g mafenide acetate (Sulfamylon®) packet
in 200 mL of either sterile water for irrigation or sterile saline for
irrigation; (minimum solubility of 50 g of mafenide is in 200 mL of either
solution)
Sterilize this solution by pushing through a 0.22 micron filter
Further dissolve this 200 mL of sterile Sulfamylon®
solution in 800 mL of the initial diluent (either sterile water for irrigation
or sterile water for irrigation)
This solution is stable and sterile for a total of 48 hours at room
temperature
Note: Mafenide acetate topical solution CANNOT be mixed with nystatin
due to reduced activity of mafenide
Note: Pilot in vitro studies:
Silvadene® and Furacin® cream
combined with nystatin cream were equally effective against the microorganisms
as were the individual drugs. However, Sulfamylon® cream
combined with nystatin lost its antimicrobial capability. [J Burn Care Rehabil
1989;109(6):508-11.] |
|
|
Mechanism of
Action |
|
Interferes with bacterial folic acid synthesis through competitive inhibition
of para-aminobenzoic acid |
|
|
Pharmacodynamics/Kinetics |
|
Absorption: Diffuses through devascularized areas and is rapidly absorbed
from burned surface
Metabolism: To para-carboxybenzene sulfonamide which is a carbonic anhydrase
inhibitor
Time to peak serum concentration: Topical: 2-4 hours
Elimination: In urine as metabolites |
|
|
Usual Dosage |
|
Children and Adults: Topical: Apply once or twice daily with a sterile gloved
hand; apply to a thickness of approximately 16 mm; the burned area should be
covered with cream at all times |
|
|
Monitoring
Parameters |
|
Acid base balance |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
For external use only. Apply exactly as directed with sterile gloved hand so
that burned areas are covered with cream at all times. Avoid getting in eyes.
Report facial swelling, skin rash, unusual bleeding, difficulty breathing, or
signs of infections. Pregnancy/breast-feeding precautions: Inform
prescriber if you are or intend to be pregnant. Consult prescriber if
breast-feeding. |
|
|
Nursing
Implications |
|
For external use only
Monitor acid base balance |
|
|
Dosage Forms |
|
Cream, topical, as acetate: 85 mg/g (56.7 g, 113.4 g, 411 g)
Powder, topical: 5% (50 g) |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|